Similar Search Results

Estimating the social and economic benefits of pharmaceutical innovation : modeling clinical trial results in HIV-disease

Simpson, Kit (contributor) - In: Investing in health : the social and economic benefits …, (pp. 175-196). 2001

Persistent link: https://www.econbiz.de/10001640134

Drugs, market size and population

Cerda, Rodrigo - 2003

Persistent link: https://www.econbiz.de/10001825898

Survey of pharmacoeconomic assessment activity in eleven countries

Dickson, Michael (contributor); Hurst, Jeremy (contributor); … - 2003 - [Elektronische Ressource]

Persistent link: https://www.econbiz.de/10002049750

Innovation under federal health care reform

Sisk, Jane E. - In: Health affairs : at the intersection of health, health … 13 (1994) 3, pp. 82-97

Persistent link: https://www.econbiz.de/10001169009

Medical innovation duels cost containment

Rettig, Richard A. - In: Health affairs : at the intersection of health, health … 13 (1994) 3, pp. 7-27

Persistent link: https://www.econbiz.de/10001169010

Does medicaid pay too much for precscription drugs? : A case study of atypical anti-psychotics

Duggan, Mark G. - 2003

Persistent link: https://www.econbiz.de/10001753201

The regulation of medical innovation and pharmaceutical markets : a conference ; [Conference the Regulation of Medical Innovation and Pharmaceutical Markets held at the University...

2003

Persistent link: https://www.econbiz.de/10001774978

Patenting Medical Products

Wijesinghe, Prasadi - 2018

The new creations and innovations which are formulated in the minds of the human minds are recognized as a mode of an intangible property which, people can enjoy a specific set of rights over them. These are called 'intellectual property' as it is attached with the intellect of the people.There...

Persistent link: https://www.econbiz.de/10012924441

From scientific research to healthcare markets : empirical essays on the economics of pharmaceutical innovation

Byrski, Dennis - 2021

Persistent link: https://www.econbiz.de/10012816525

The Impact of Pharmaceutical Innovation on Longevity and Medical Expenditure in Sweden, 1997-2010 : Evidence from Longitudinal, Disease-Level Data

Lichtenberg, Frank R.; Pettersson, Billie - 2021

We use longitudinal, disease-level data to analyze the impact of pharmaceutical innovation on longevity and medical … expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is … the number of drugs to treat a disease, not the number of drug classes. Pharmaceutical innovation also reduced hospital …

Persistent link: https://www.econbiz.de/10013315886